You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.
|
|---|---|
| Published in |
Journal of Clinical Oncology, October 2002
|
| DOI | 10.1200/jco.2002.11.084 |
| Pubmed ID | |
| Authors |
Deborah Schrag, Sheryl Rifas-Shiman, Leonard Saltz, Peter B. Bach, Colin B. Begg |
| Abstract |
Clinical trials have not demonstrated that adjuvant chemotherapy improves survival for patients with resected stage II colon cancer. Nevertheless, patients may receive this treatment despite its uncertain benefit. The objective of this study was to determine the extent to which adjuvant chemotherapy is used for patients with stage II colon cancer. |
Mendeley readers
The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| Ecuador | 1 | 2% |
| Unknown | 59 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 25% |
| Student > Doctoral Student | 8 | 13% |
| Student > Ph. D. Student | 5 | 8% |
| Professor > Associate Professor | 5 | 8% |
| Other | 4 | 7% |
| Other | 10 | 16% |
| Unknown | 14 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 46% |
| Agricultural and Biological Sciences | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Economics, Econometrics and Finance | 2 | 3% |
| Computer Science | 1 | 2% |
| Other | 8 | 13% |
| Unknown | 16 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2013.
All research outputs
#7,171,179
of 22,669,724 outputs
Outputs from Journal of Clinical Oncology
#11,575
of 19,853 outputs
Outputs of similar age
#15,328
of 46,447 outputs
Outputs of similar age from Journal of Clinical Oncology
#29
of 67 outputs
Altmetric has tracked 22,669,724 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 19,853 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 46,447 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.